Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong
- PMID: 20872705
- DOI: 10.1002/jmv.21895
Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong
Abstract
To study the serologic response to the new pandemic influenza A (H1N1) 2009 virus in Hong Kong, the level of immunity was measured before and after the occurrence of the outbreak, and the titer of antibody to the pandemic influenza A (H1N1) 2009 virus in serum samples of laboratory confirmed cases. The presence of pre-outbreak pandemic influenza A (H1N1) 2009 virus antibodies in 37% of individuals older than >65 years suggested previous exposures to heterologous virus strains may have elicited cross-reacting antibody. Following large outbreaks of pandemic influenza A 2009 virus that peaked in September 2009, there is a change in immunity level in various age groups consistent with the attack rates among population in Hong Kong. Among individuals with mild clinical presentation, the antibody response to pandemic influenza A (H1N1) 2009 virus was stronger in those individuals aged ≤ 24 years but took more time to reach a titer of 40 when compared with those aged >24 years; however, the antibody level declined slower among individuals aged ≤ 24 years. Regardless of age, the antibody response rose rapidly and reached much higher titer among individuals with severe clinical presentation. Further study is required to collect additional data on antibody persistence and determine how much protection is conferred by previous exposure to seasonal influenza A (H1N1) viruses.
© 2010 Wiley-Liss, Inc.
Similar articles
-
Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.Clin Microbiol Infect. 2012 Feb;18(2):177-83. doi: 10.1111/j.1469-0691.2011.03545.x. Epub 2011 Jun 2. Clin Microbiol Infect. 2012. PMID: 21635661
-
Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.N Engl J Med. 2009 Nov 12;361(20):1945-52. doi: 10.1056/NEJMoa0906453. Epub 2009 Sep 10. N Engl J Med. 2009. PMID: 19745214
-
[A survey of levels of antibodies against influenza viruses in the population of Wuxi City].Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Oct;25(5):351-4. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011. PMID: 22338222 Chinese.
-
The first pandemic of the 21st century: a review of the 2009 pandemic variant influenza A (H1N1) virus.Postgrad Med. 2009 Sep;121(5):43-7. doi: 10.3810/pgm.2009.09.2051. Postgrad Med. 2009. PMID: 19820273 Review.
-
A novel H1N1 virus causes the first pandemic of the 21st century.Eur J Immunol. 2009 Nov;39(11):2946-54. doi: 10.1002/eji.200939911. Eur J Immunol. 2009. PMID: 19790188 Review.
Cited by
-
Determining Existing Human Population Immunity as Part of Assessing Influenza Pandemic Risk.Emerg Infect Dis. 2022 May;28(5):977-985. doi: 10.3201/eid2805.211965. Emerg Infect Dis. 2022. PMID: 35447069 Free PMC article.
-
The contribution of social behaviour to the transmission of influenza A in a human population.PLoS Pathog. 2014 Jun 26;10(6):e1004206. doi: 10.1371/journal.ppat.1004206. eCollection 2014 Jun. PLoS Pathog. 2014. PMID: 24968312 Free PMC article.
-
Searching for sharp drops in the incidence of pandemic A/H1N1 influenza by single year of age.PLoS One. 2012;7(8):e42328. doi: 10.1371/journal.pone.0042328. Epub 2012 Aug 2. PLoS One. 2012. PMID: 22876316 Free PMC article.
-
The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong.Influenza Other Respir Viruses. 2013 May;7(3):367-82. doi: 10.1111/j.1750-2659.2012.00420.x. Epub 2012 Aug 9. Influenza Other Respir Viruses. 2013. PMID: 22883352 Free PMC article. Review.
-
The role of social contacts and original antigenic sin in shaping the age pattern of immunity to seasonal influenza.PLoS Comput Biol. 2012;8(10):e1002741. doi: 10.1371/journal.pcbi.1002741. Epub 2012 Oct 25. PLoS Comput Biol. 2012. PMID: 23133346 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical